Tag Archives: bifurcations

The Visible Heart Lab

04/23 – SOLACI-Medtronic Webinar | The Visible Heart Lab. Register now

04/23 – SOLACI-Medtronic Webinar | The Visible Heart Lab. Register now

A new joint event between SOLACI and Medtronic is coming up. In this case, it will consist of a live session in which the focus will be on provisional bifurcation techniques and access to the lateral branch and on current challenges in bifurcations. Leading faculties and international operators will participate in the event, which is

Diabetes y enfermedad vascular periférica: viejas drogas con nueva evidencia

BIFURCAT Registry: Long Term Diabetes Impact on Bifurcations PCI Outcomes

The impact of diabetes in patients with coronary artery disease (CAD) are well known, and after percutaneous coronary intervention (PCI), outcomes tend to be less favorable, with higher restenosis rate, repeat myocardial infarction (MI) and stent thrombosis. Despite the development of drug eluting stents, procedures and techniques, treating bifurcation lesions in diabetic patients still show

SOLACI Y LATAM Bif realizaron un taller de bifurcaciones en México

SOLACI and LATAM Bif Conducted an Intensive Workshop on Bifurcations in Mexico

As a part of its mission to help interventional cardiology grow in Latin America, SOLACI alongside LATAM Bif coordinated a Workshop on Bifurcations with renowned professionals from the Torreón (Coahuila) region in Mexico, a place that is 1000 kilometers away from Mexico City. This activity, which took place on February 17, is part of the Medtronic

perforación coronaria en angioplastia

Coronary Bifurcation Lesions: MRS or PCI? 10-Year Mortality of the SYNTAX Study

Percutaneous treatment of coronary lesions affecting bifurcations has increased in recent decades. Coronary angioplasty (percutaneous coronary intervention, PCI) in these cases is associated with an increased rate of adverse events in patients with multivessel disease and left main coronary artery lesions. The SYNTAX score, which is a predictor of total mortality, is used to evaluate

10 Years Treating Bifurcations: Have We Made Progress?

Bifurcations have been, are and will be challenging. However, we have to admit we have gained experience and have more tools than pioneer interventionists and many of the early experts who have made history.  This study assessed the ten-year trends in coronary bifurcation percutaneous coronary intervention (PCI) looking at patient and lesion characteristics, devices used,

The Fellow’s Corner | 3rd Clinical Case: True Bifurcation Lesion: Which Strategy Should We Use?

Here is the third Fellow’s Corner clinical case to keep discussing and learning alongside the entire community of hemodynamics fellows in Latin America. In this instance, we will present a case of True Bifurcation Lesion: Which Strategy Should We Use? Content 1- Case Presentation 2- Case Resolution 3- Expert Commentary Authors: Dr. Carlos Fava (ARG)

Reporte Mensual Febrero Registro LATAM Bif

LATAMBif Registry: February 2021 Report

The Latin American Registry of Percutaneous Coronary Bifurcations continues to develop at a steady pace.  The aim of this prospective multicenter registry is to assess the reality of percutaneous coronary bifurcation to define its needs and establish effective strategies to perfect the daily clinical practice.  Bellow you will find data from February 2021, which includes

Webinar SOLACI 03-03 | Angioplastia de Tronco de Coronaria Izquierda y Bifurcaciones: Registro LATAM Bif

Watch again our Webinar on Left Main PCI and Bifurcations: LATAM Bif Registry

Watch again our Webinar on “Left Main PCI and Bifurcations: LATAM Bif Registry” on our Youtube account. The event was held on March 3rd, 2021, and had the participation of almost 700 people and the support of ABBOTT, Boston Scientific, Medtronic and Terumo. Webinar Contents 00:02​​ | Introduction – Dr. José Mangione (BRA). 04:58​ |